influenza
viru
rna
replic
requir
intric
regulatori
network
involv
viral
cellular
protein
studi
examin
role
cellular
ubiquitinatingdeubiquitin
enzym
dub
observ
downregul
cellular
deubiquitin
enzym
result
enhanc
viru
product
suggest
could
inhibit
influenza
viru
replic
convers
overexpress
specif
inhibit
viral
genom
rna
replic
inhibit
requir
deubiquitinas
activ
furthermor
show
interact
pa
np
viral
rna
replic
complex
np
monoubiquitin
protein
deubiquitin
vivo
final
identifi
ubiquitin
site
np
residu
crucial
viru
rna
replic
propos
ubiquitinationdeubiquitin
np
manipul
antivir
therapeut
purpos
embo
journal
vol
embo
embo
journal
embo
journal
influenza
viru
rna
replic
tl
liao
et
al
influenza
viru
envelop
negativesens
rna
viru
caus
major
public
health
problem
worldwid
everi
year
global
burden
influenza
epidem
believ
million
case
sever
ill
influenza
viru
like
virus
reli
viral
protein
also
host
cell
protein
associ
mechan
complet
viral
life
cycl
identifi
host
molecul
particip
step
viru
replic
could
provid
valuabl
new
target
antivir
therapi
hao
et
al
karla
et
al
et
al
influenza
viru
contain
eight
segment
singlestrand
negativesens
rna
genom
rna
segment
packag
ribonucleoprotein
rnp
complex
consist
viral
nucleoprotein
np
viral
rna
polymeras
rna
genom
transcrib
replic
viral
rnadepend
rna
polymeras
cell
nucleu
viral
rna
polymeras
consist
three
subunit
polymeras
basic
protein
polymeras
basic
protein
polymeras
acid
protein
pa
togeth
respons
transcript
replic
viral
genom
wright
et
al
howev
precis
molecular
mechan
viral
genom
replic
fulli
understood
still
unknown
switch
transcript
replic
regul
although
report
np
protein
import
function
switch
portela
digard
posttransl
modif
protein
ubiquitin
ub
key
regulatori
event
variou
cellular
activ
includ
signal
transduct
transcript
membran
protein
traffick
nuclear
transport
autophagi
immun
respons
welchman
et
al
ubiquitin
dynam
revers
process
becom
increasingli
evid
deubiquitin
also
import
function
regul
ubiquitindepend
pathway
less
well
understood
eukaryot
virus
known
modul
protein
ubiquitin
advantag
variou
way
sever
virus
shown
depend
proteasom
certain
cellular
ligas
entri
releas
yu
lai
bieniasz
moreov
mani
virus
regul
protein
ubiquitin
overcom
host
cell
defens
mechan
includ
major
histocompat
complex
mhc
antigen
present
interferon
respons
apoptosi
end
numer
virus
encod
protein
redirect
cellular
ligas
ubiquitinproteasom
system
up
protein
antivir
activ
includ
tumor
suppressor
protein
activ
transcript
signal
transduc
lindner
contrast
ubiquitin
exampl
target
protein
deubiquitin
system
virus
report
includ
specif
target
cellular
epsteinbarr
nuclear
herp
simplex
viru
regulatori
protein
everett
et
al
holowati
frappier
addit
ubiquitin
also
regul
function
viral
protein
human
immunodefici
viru
tat
protein
observ
addit
singl
ubiquitin
molecul
cterminu
increas
transcript
function
bre
et
al
howev
tax
protein
monoubiquitin
led
lower
transcript
activ
pelopones
et
al
addit
gag
monoubiquitin
import
virion
format
et
al
recent
studi
also
found
ubiquitin
requir
effici
replic
coxsackieviru
data
suggest
proteasom
inhibitor
reduc
coxsackieviru
replic
inhibit
viral
rna
transcript
protein
synthesi
si
et
al
similar
result
also
observ
influenza
viru
rodriguez
et
al
viral
protein
synthesi
inhibit
treatment
zleuleuleu
result
indic
ubiquitinproteasom
pathway
may
involv
influenza
viru
replic
earli
phase
viral
life
cycl
studi
develop
valid
vitro
cellbas
assay
highthroughput
screen
rnai
librari
search
cellular
ubiquitinas
deubiquitinas
involv
influenza
viru
replic
rnai
screen
identifi
new
cellular
deubiquitinas
regul
influenza
viru
rna
replic
furthermor
influenza
viru
np
protein
monoubiquitin
protein
deubiquitin
specif
ubiquitin
deubiquitin
np
probabl
regul
influenza
viral
genom
replic
studi
first
develop
valid
cellbas
assay
highthroughput
screen
rnai
librari
cellular
factor
involv
influenza
viru
replic
assay
base
determin
cell
viabil
ratio
specif
cellular
gene
knockdown
cell
infect
without
influenza
viru
assay
develop
figur
defin
optim
detect
method
plate
densiti
optim
multipl
infect
moi
posit
lentiviru
knockdown
clone
control
cell
cultur
plate
first
infect
specif
lentiviru
clone
moi
clone
repres
four
replica
select
puromycin
treatment
mgml
day
two
four
well
infect
influenza
viru
moi
h
infect
cell
viabil
assay
perform
cell
viabil
ratio
cell
infect
without
influenza
viru
calcul
normal
condit
ratio
posit
control
screen
panel
use
wellcharacter
cellular
inhibitor
influenza
viru
infect
lenschow
et
al
expect
cellular
knock
cell
viabil
ratio
decreas
indic
cell
kill
influenza
viru
infect
absenc
ubiquitinlik
protein
hypothes
ubiquitinlik
protein
may
also
involv
influenza
viru
life
cycl
therefor
chose
dub
deubiquitin
enzym
rnai
librari
subset
screen
clone
trc
rnai
dub
librari
includ
human
dub
gene
supplementari
tabl
criterion
determin
hit
screen
set
reduct
increas
cell
viabil
ratio
five
separ
clone
dub
gene
three
clone
conform
criterion
consid
candid
gene
basi
criterion
novel
cellular
deubiquitinas
identifi
candid
gene
regul
influenza
viru
replic
product
rnai
primari
screen
result
show
cellular
knock
influenza
viru
product
enhanc
evidenc
lower
cell
viabil
higher
cpe
therefor
studi
possibl
mechan
inhibit
rnai
detail
immunoblot
result
show
among
five
clone
clone
best
knockdown
effici
figur
therefor
clone
use
studi
verifi
involv
influenza
viru
infect
knockdown
cell
infect
influenza
viru
moi
h
infect
cultur
medium
collect
plaqu
assay
perform
determin
viru
titer
result
show
cellular
knock
viru
titer
increas
figur
addit
overexpress
cell
influenza
viru
product
reduc
figur
significantli
cell
transfect
express
form
resist
suppress
wobbl
mutat
influenza
viru
titer
drop
level
wildtyp
cell
figur
rescu
experi
confirm
effect
lentiviru
clone
specif
due
knockdown
taken
togeth
conclud
inhibit
influenza
viru
product
immunofluoresc
stain
result
show
primarili
locat
nucleu
cell
previous
report
ideguchi
et
al
data
shown
therefor
determin
role
influenza
viru
life
cycl
first
focus
viral
replic
transcript
take
place
nucleu
knockdown
cell
infect
influenza
viru
moi
singlecycl
viru
infect
h
infect
total
cellular
rna
use
primer
extens
analysi
detect
viral
segment
na
vrna
crna
mrna
use
respect
primer
set
chan
et
al
figur
left
panel
level
vrna
crna
knockdown
cell
significantli
higher
control
cell
mrna
amount
almost
control
knockdown
cell
also
develop
quantit
rtpcr
qrtpcr
procedur
verifi
reduct
vrna
qrtpcr
protocol
modifi
publish
data
tseng
et
al
design
specif
tag
primer
detect
vrna
supplementari
tabl
ii
qrtpcr
result
confirm
primer
extens
data
figur
right
panel
elucid
whether
inhibit
influenza
viru
replic
requir
deubiquitin
enzym
activ
catalyt
defect
mutant
transfect
cell
cell
infect
viru
moi
singlecycl
viru
infect
level
vrna
crna
cell
overexpress
wildtyp
reduc
control
cell
figur
signific
reduct
vrna
crna
cell
express
catalyt
defect
mutant
figur
lane
result
indic
inhibit
vrna
crna
synthesi
therefor
conclud
inhibit
influenza
viru
rna
replic
depend
deubiquitin
enzym
activ
particular
experi
slight
decreas
viral
mrna
cell
reduct
could
secondari
effect
reduct
vrna
mrna
made
use
vrna
templat
address
possibl
dissect
viral
transcript
activ
independ
viru
genom
replic
determin
level
viral
mrna
synthesi
presenc
cycloheximid
chx
shown
chx
suppress
viral
protein
synthesi
therebi
inhibit
viru
genom
rna
replic
mrna
transcript
latter
need
new
protein
synthesi
vreed
et
al
control
cell
figur
taken
togeth
result
indic
primarili
inhibit
influenza
viru
rna
replic
deubiquitin
enzym
activ
deubiquitinas
hypothes
compon
viral
rnp
may
substrat
first
determin
whether
bind
viral
rnp
compon
perform
coimmunoprecipit
assay
use
cell
lysat
prepar
cell
transient
express
myctag
one
hatag
viral
rnp
protein
lysat
immunoprecipit
antimyc
agaros
blot
antiha
antibodi
shown
figur
pa
np
specif
coprecipit
lane
respect
howev
coprecipit
detect
lane
lane
lane
coprecipit
detect
antimyc
antibodi
absent
lane
either
two
construct
omit
figur
result
indic
specif
interact
influenza
viral
rnp
complex
member
ubiquitinspecif
proteas
usp
famili
mediat
remov
process
ubiquitin
coimmunoprecipit
result
show
interact
pa
np
respect
addit
ubiquitin
observ
influenza
viru
particl
shaw
et
al
hypothes
one
rnp
complex
subunit
may
candid
substrat
ubiquitin
requir
influenza
viru
rna
replic
verifi
hypothesi
first
attempt
detect
ubiquitin
viral
protein
cell
ubiquitin
ub
coexpress
paha
npha
respect
cell
hatag
immunoprecipit
subject
immunoblot
analysi
antiha
antinp
antibodi
respect
result
show
np
besid
np
addit
band
size
kda
consist
monoubiquitin
form
np
detect
coexpress
ubiquitin
figur
lane
result
suggest
np
monoubiquitin
addit
pa
cotransfect
ub
highmolecular
weight
smear
detect
antiha
figur
lane
antimyc
antibodi
figur
lower
panel
lane
respect
indic
pa
polyubiquitin
protein
comparison
largermolecular
weight
form
detect
figur
lower
panel
lane
verifi
np
monoubiquitin
protein
cotransfect
plasmid
express
npha
mycub
subject
hatag
immunoprecipit
immunoblot
analysi
use
indic
antibodi
result
figur
show
np
ub
present
lane
addit
npub
form
similar
previou
data
figur
band
could
detect
antimyc
antibodi
indic
ubiquitin
protein
lane
np
ub
coexpress
npub
signal
diminish
lane
wherea
mt
reduc
npub
signal
lane
result
shown
figur
indic
pa
polyubiquitin
protein
coprecipit
therefor
also
perform
similar
experi
determin
whether
pa
substrat
shown
figur
pa
substrat
lane
mayer
et
al
identifi
sever
cellular
interact
partner
influenza
viru
rnp
complex
use
proteomicbas
approach
one
protein
identifi
determin
whether
ubiquitin
np
specif
deubiquitin
cotransfect
plasmid
express
npha
mycub
subject
hatag
immunoprecipit
immunoblot
analysi
use
indic
antibodi
figur
result
show
specif
coprecipit
npha
lane
lower
panel
consist
publish
result
np
could
deubiquitin
lane
upper
panel
taken
togeth
conclud
np
monoubiquitin
protein
deubiquitin
specif
np
possess
region
highli
conserv
among
variou
influenza
viru
strain
identifi
ubiquitin
site
np
perform
sitedirect
mutagenesi
replac
crucial
conserv
lysin
residu
arginin
base
publish
report
li
et
al
express
hatag
form
mutant
wildtyp
np
togeth
ub
cell
result
show
wild
type
mutant
np
includ
mutant
modifi
ubiquitin
figur
result
indic
import
np
ubiquitin
may
ubiquitin
site
sequenc
align
show
highli
conserv
among
differ
subtyp
influenza
viru
influenza
b
viru
figur
assess
effect
viral
rna
replic
transcript
test
replic
function
use
minireplicon
system
li
et
al
contain
luciferas
report
assay
viral
rna
replic
activ
result
show
substitut
arginin
replic
transcript
activ
decreas
supplementari
figur
indic
import
viral
rna
replic
consist
recent
studi
wasilenko
et
al
inconsist
anoth
report
li
et
al
repeat
minireplicon
experi
knockdown
cell
figur
cotransfect
plasmid
express
ub
control
grey
bar
result
show
luciferas
activ
mutant
low
wildtyp
construct
knockdown
cell
differ
versu
two
approach
suggest
may
addit
target
cell
addit
note
luciferas
activ
mutant
affect
overexpress
ubiquitin
wherea
luciferas
activ
increas
wt
np
mutant
includ
data
taken
togeth
support
hypothesi
replic
defect
like
due
failur
ubiquitin
among
np
mutant
mutant
total
devoid
luciferas
activ
indic
crucial
viral
genom
replic
andor
transcript
reason
ubiquitin
consist
previou
studi
demonstr
mutat
block
interact
np
two
polymeras
subunit
biswa
et
al
li
et
al
recent
studi
show
direct
interact
np
viral
polymeras
result
modif
polymeras
favour
unprim
initi
rna
replic
newcomb
et
al
addit
biswa
et
al
show
np
interact
pa
determin
whether
defect
replic
caus
impair
interact
viral
polymeras
cotransfect
plasmid
express
ha
subject
hatag
immunoprecipit
immunoblot
analysi
use
indic
antibodi
result
figur
show
signific
differ
interact
wildtyp
np
lane
lane
therefor
defect
replic
caus
defect
interact
viru
polymeras
next
examin
whether
mutat
affect
bind
np
vrna
rna
bind
protein
immunoprecipit
rip
assay
knockdown
cell
cotransfect
plasmid
express
ha
mycub
ppoliluc
produc
vrnalik
molecul
subject
hatag
immunoprecipit
isol
npvrna
complex
immunoblot
result
show
np
protein
express
level
equival
reaction
figur
upper
panel
vrna
isol
rnp
complex
quantifi
qrtpcr
figur
figur
also
produc
recombin
viru
incorpor
substitut
revers
genet
techniqu
hoffmann
et
al
examin
biolog
properti
plaqu
size
mutant
viru
smaller
wildtyp
figur
viru
growth
curv
data
figur
also
indic
mutant
viru
defect
viru
product
earli
time
consist
defect
rna
replic
figur
dissect
role
np
ubiquitin
viral
rna
synthesi
cell
infect
mutant
moi
total
cellular
rna
use
primer
extens
analysi
indic
time
point
figur
right
upper
panel
h
infect
vrna
repres
viral
genom
rna
deriv
infect
viru
particl
detect
figur
lane
amount
crna
vrna
increas
h
infect
rna
replic
proceed
lane
wildtyp
rna
lane
mutant
rna
respect
significantli
vrna
crna
amount
mutant
less
wild
type
time
point
except
h
indic
mutant
viru
defect
viru
rna
replic
like
due
lack
ubiquitin
contrast
mrna
amount
similar
mutant
wildtyp
throughout
lane
suggest
np
ubiquitin
involv
viral
mrna
transcript
also
perform
qrtpcr
detect
vrna
figur
right
lower
panel
result
show
h
infect
vrna
amount
decreas
time
point
mrna
amount
also
decreas
probabl
secondari
effect
reduct
vrna
therefor
result
show
np
crucial
viral
rna
replic
final
perform
addit
experi
directli
demonstr
np
protein
ubiquitin
viru
infect
knockdown
cell
transfect
plasmid
express
mycub
h
transfect
cell
infect
wildtyp
mutant
viru
moi
h
infect
cell
lysat
subject
immunoprecipit
antimyc
antiub
antibodi
immunoprecipit
subject
immunoblot
analysi
use
antinp
antibodi
result
figur
show
npub
signal
detect
wildtyp
lane
mutant
viru
lane
indic
np
protein
ubiquitin
viru
infect
taken
togeth
conclud
ubiquitin
site
np
protein
crucial
viral
rna
replic
increas
rnabind
affin
dissect
mechan
inhibit
influenza
viru
rna
replic
knockdown
control
cell
infect
wildtyp
mutant
viru
moi
total
cellular
rna
use
primer
extens
qrtpcr
analysi
h
infect
cellular
knock
amount
vrna
crna
wildtyp
viru
increas
figur
lane
versu
lane
indic
inhibit
viral
rna
replic
previous
mention
mutant
viru
defect
np
ubiquitin
howev
signific
differ
viral
rna
synthesi
knockdown
control
cell
figur
lane
furthermor
amount
viral
rna
mutant
lower
wild
type
wildtyp
cell
infect
wildtyp
viru
see
lane
addit
differ
amount
vrna
wildtyp
mutant
virus
knockdown
cell
lane
versu
lane
also
perform
convers
experi
name
control
cell
infect
wildtyp
mutant
viru
figur
amount
vrna
crna
wildtyp
viru
cell
overexpress
wildtyp
reduc
control
cell
figur
lane
versu
lane
cell
express
catalyt
defect
mutant
lane
contrast
overexpress
affect
amount
vrna
crna
mutant
viru
lane
interestingli
amount
wildtyp
vrna
overexpress
cell
almost
mutant
lane
versu
lane
result
consist
minireplicon
data
supplementari
figur
result
combin
suggest
inhibit
viral
rna
replic
deubiquitin
np
consequ
np
ubiquitin
defect
mutant
viru
effect
cellular
inhibit
diminish
result
support
conclus
inhibit
viral
rna
replic
deubiquitin
np
ubiquitin
posttransl
modif
ubiquitin
chain
singl
ubiquitin
molecul
link
target
protein
give
rise
polyor
monoubiquitin
weissman
polyubiquitin
chain
four
subunit
longer
requir
effici
recognit
degrad
ubiquitin
protein
proteasom
function
ubiquitin
involv
proteasom
also
demonstr
protein
modifi
singl
ubiquitin
short
ubiquitin
chain
instead
send
protein
death
proteasom
monoubiquitin
regul
locat
activ
divers
cellular
protein
histon
wellcharacter
monoubiquitin
protein
previou
studi
shown
ubiquitin
may
alter
conform
oligomer
state
histon
thu
affect
proteinprotein
proteinnucl
acid
interact
hick
prolifer
cell
nuclear
antigen
pcna
anoth
exampl
monoubiquitin
modif
regul
pcna
load
onto
dna
strand
trimer
ring
function
clamp
process
factor
dna
polymeras
essenti
dna
replic
dna
repair
silenc
exposur
human
cell
dnadamag
agent
block
progress
replic
fork
monoubiquitin
pcna
mediat
switch
replic
dna
polymeras
polymeras
special
transles
synthesi
kannouch
et
al
previou
literatur
shown
up
import
function
earli
step
influenza
viru
infect
treatment
host
cell
anoth
proteasom
inhibitor
lactacystin
affect
earli
stage
viru
replic
confoc
laser
scan
microscop
imag
show
influenza
viru
select
use
ubiquitinvacuolar
proteinsort
pathway
entri
host
cell
khor
et
al
recent
shaw
et
al
use
two
complementari
mass
spectrometri
approach
perform
comprehens
proteom
analysi
purifi
influenza
viru
particl
ubiquitin
among
hostencod
protein
influenza
viru
particl
studi
identifi
deubiquitin
enzym
new
cellular
factor
involv
influenza
viru
rna
replic
interact
pa
np
protein
subunit
viral
rnp
complex
furthermor
could
cleav
monoubiquitin
np
protein
specif
test
deubiquitinas
includ
neither
regul
influenza
viru
rna
replic
cs
tseng
unpublish
observ
origin
isol
character
name
ubiquitin
ctermin
hydrolas
x
chromosom
swanson
et
al
contain
cy
box
respons
deubiquitin
activ
ubiquiti
protein
distribut
across
wide
rang
human
tissu
local
nucleu
demonstr
interact
ranbpm
ranbind
protein
requir
correct
microtubul
nucleat
ideguchi
et
al
publish
result
also
show
particip
dnadamag
repair
function
within
pathway
independ
deubiquitin
schoenfeld
et
al
also
regul
ikb
kinasea
ikka
signal
pathway
respons
tumor
necrosi
factora
tnfa
yamaguchi
et
al
recent
studi
show
stabil
regul
biolog
activ
lin
et
al
interestingli
two
group
also
observ
requir
west
nile
viru
hepat
c
viru
infect
mechan
remain
unknown
krishnan
et
al
li
et
al
influenza
viru
nucleoprotein
np
basic
rnabind
protein
phosphoryl
vivo
wright
et
al
bind
singlestrand
rna
sequenc
specif
interact
basic
residu
phosphodiest
backbon
stack
aromat
residu
nucleotid
base
ye
et
al
ntermin
portion
np
bear
rnabind
domain
subdivid
two
smaller
region
residu
retain
rnabind
activ
albo
et
al
owe
bind
ssrna
np
abl
selfassoci
form
larg
oligom
addit
np
interact
varieti
macromolecul
viral
cellular
origin
shown
np
interact
directli
pa
biswa
et
al
interact
rnp
complex
specif
interact
np
ye
et
al
believ
interact
np
requir
virion
assembl
furthermor
np
interact
sever
cellular
protein
includ
filament
f
actin
digard
et
al
nuclear
import
receptor
importina
class
oneil
pales
nuclear
export
receptor
elton
et
al
rnp
complex
basic
function
unit
replic
transcript
influenza
viral
genom
previou
data
shown
templates
rna
synthes
np
rnp
complex
honda
et
al
np
essenti
synthesi
vrna
crna
shapiro
krug
sever
hypothes
propos
role
np
switch
mrna
crna
synthesi
portela
digard
encapsid
hypothesi
propos
np
regulatori
function
mere
essenti
cofactor
coat
nascent
crna
vrna
segment
shapiro
krug
templat
modif
hypothesi
consid
np
regul
transcript
initi
termin
interact
templat
rna
chang
structur
hsu
et
al
klumpp
et
al
polymeras
modif
hypothesi
propos
abil
np
bind
directli
alter
transcript
activ
polymeras
direct
proteinprotein
interact
biswa
et
al
moreov
recent
studi
show
direct
interact
np
viral
polymeras
result
modif
polymeras
favour
unprim
initi
newcomb
et
al
result
shown
inhibit
influenza
viru
rna
replic
np
monoubiquitin
protein
deubiquitin
specif
also
identifi
ubiquitin
site
np
mutat
viral
genom
replic
inhibit
consist
recent
publish
data
wasilenko
et
al
howev
extent
interact
viru
polymeras
similar
wildtyp
np
polymeras
result
consist
previou
studi
demonstr
fragment
np
interact
viral
polymeras
includ
biswa
et
al
addit
protein
structur
studi
influenza
viru
np
reveal
potenti
rnabind
pocket
consist
sever
posit
charg
amino
acid
includ
ye
et
al
posit
charg
may
facilit
bind
neg
charg
rna
howev
data
show
even
substitut
posit
charg
arginin
vrnabind
affin
viru
rna
replic
still
defect
indic
defect
rna
replic
caus
reduct
vrnabind
affin
impair
np
ubiquitin
note
protein
modif
ubiquitin
dynam
process
constantli
ubiquitin
deubiquitin
therefor
even
though
biochem
studi
show
small
fraction
np
ubiquitin
larger
fraction
np
molecul
could
fact
ubiquitin
vreed
et
al
propos
stabil
model
nascent
crna
degrad
host
cell
nucleas
unless
stabil
newli
synthes
viral
rna
polymeras
np
basi
model
mrna
crna
synthes
earli
infect
crna
degrad
howev
later
infect
viral
polymeras
np
synthes
crna
stabil
crnp
complex
replic
vrna
addit
recent
studi
perez
et
al
show
influenza
virusderiv
small
viral
rna
svrna
trigger
viral
switch
transcript
replic
interact
viral
polymeras
machineri
result
show
signific
differ
interact
wildtyp
np
subunit
viral
polymeras
addit
studi
also
show
ubiquitin
np
alter
interact
np
rna
hypothes
monoubiquitin
np
alter
interact
np
rna
thu
stabil
crna
therebi
increas
rna
replic
effici
figur
transcript
possibl
multipl
factor
regul
differ
step
viral
rna
replic
transcript
convers
cellular
deubiquitinas
interact
pa
np
therebi
affect
function
rnp
complex
rna
replic
significantli
cleav
singl
ubiquitin
np
therebi
inhibit
rna
replic
effici
figur
mechan
offer
new
way
finetun
viral
rna
replic
np
modif
vreed
et
al
lower
panel
ubiquitin
viral
np
protein
may
increas
bind
affin
crna
therebi
stabil
crnp
increas
rna
replic
b
deubiquitin
np
cellular
may
lower
bind
affin
crna
addit
also
interact
viral
pa
protein
therebi
inhibit
viral
rna
replic
rnai
reagent
purchas
nation
rnai
core
facil
locat
institut
molecular
biologygenom
research
center
academia
sinica
support
nation
research
program
genom
medicin
grant
nsc
nsc
target
effect
lentivirusbas
rnai
control
rnai
shluc
cell
seed
appropri
densiti
ml
per
well
ml
per
well
tissu
cultur
plate
incub
overnight
cell
maintain
dmem
contain
mgml
polybren
rnai
lentiviru
ad
cell
moi
incub
overnight
medium
replac
fresh
medium
contain
mgml
puromycin
incub
day
primari
rnai
screen
cell
viabil
assay
perform
use
celltit
glo
luminesc
cell
viabil
kit
promega
accord
manufactur
protocol
detail
provid
supplementari
data
primer
extens
assay
perform
use
primer
extens
systemamv
revers
transcriptas
kit
promega
total
mg
total
rna
mix
pmole
two
dna
primer
label
end
p
atp
polynucleotid
kinas
promega
mixtur
heat
h
follow
cool
room
temperatur
min
primer
extens
perform
addit
u
avian
myeloblastosi
viru
revers
transcriptas
promega
reaction
buffer
provid
enzym
h
two
naspecif
primer
use
revers
transcript
reaction
tg
detect
vrna
tccagtatggt
detect
crna
mrna
vreed
et
al
sequenc
use
primer
detect
rrna
chan
et
al
transcript
product
analys
polyacrylamid
gel
contain
urea
tbe
buffer
detect
autoradiographi
quantit
rtpcr
total
rna
extract
use
rneasi
mini
kit
qiagen
accord
manufactur
protocol
subject
revers
transcript
specif
primer
vrna
supplementari
tabl
ii
detect
vrna
ng
total
rna
revers
transcrib
final
reaction
mixtur
volum
contain
rtth
revers
transcriptas
buffer
mm
rt
primer
u
rnaseout
recombin
rnase
inhibitor
invitrogen
mm
mncl
mm
datp
dgtp
dctp
dttp
invitrogen
u
rtth
appli
biosystem
rt
reaction
perform
min
termin
ad
ml
chelat
buffer
singlestrand
cdna
subject
realtim
quantit
pcr
use
quantitect
sybr
green
pcr
kit
qiagen
specif
primer
set
briefli
ml
serial
dilut
cdna
mix
ml
master
mixtur
reaction
consist
initi
step
min
follow
cycl
amplif
cycl
consist
reaction
data
acquisit
analys
perform
use
icycl
system
biorad
cell
transfect
dish
use
lipofectamin
invitrogen
accord
manufactur
direct
approxim
h
transfect
cell
wash
tb
lyse
ml
mper
reagent
pierc
centrifug
g
min
ml
whole
cell
extract
incub
ml
indic
antibodi
agaros
slurri
pierc
rotat
overnight
column
wash
three
time
tbst
buffer
elut
ml
nonreduc
sampl
buffer
pierc
sampl
analys
western
blot
use
indic
antibodi
determin
polymeras
activ
replic
complex
contain
np
mutant
minireplicon
use
firefli
luciferas
report
system
use
li
et
al
cell
cotransfect
plasmid
express
viral
protein
pa
np
wild
type
substitut
mutant
ppoliluc
renilla
luciferaseexpress
plasmid
use
intern
control
normal
transfect
effici
h
transfect
cell
collect
luciferas
activ
measur
use
dualglo
luciferas
assay
system
promega
accord
manufactur
protocol
plasmiddriven
revers
genet
recombin
viru
use
studi
gener
revers
genet
eight
fragment
viral
genom
amplifi
rtpcr
viral
cdna
insert
vector
contain
cmv
promot
similar
recombin
virus
gener
eight
plasmid
cotransfect
cell
hoffmann
et
al
supernat
collect
titrat
froze
readi
use
rip
assay
perform
use
magna
rip
tm
kit
millipor
knockdown
cell
transfect
dish
use
lipofectamin
invitrogen
accord
manufactur
direct
approxim
h
transfect
cell
wash
twice
icecold
pb
scrape
centrifug
rpm
min
discard
supernat
cell
lyse
ml
complet
rip
lysi
buffer
ml
whole
cell
extract
incub
ml
rip
immunoprecipit
buffer
contain
hatag
magnet
bead
rotat
overnight
sampl
wash
three
time
rip
wash
buffer
ml
sampl
analys
immunoblot
use
indic
antibodi
check
immunoprecipit
effici
remnant
sampl
incub
proteinas
k
buffer
min
shake
digest
protein
rna
extract
use
standard
phenolchloroform
protocol
subject
qrtpcr
specif
primer
supplementari
tabl
ii
supplementari
data
avail
embo
journal
onlin
http
wwwembojournalorg
